MENU
Cart

There is no item in your cart

Description

What do you know about Qelbree?

Qelbree vs Strattera is a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents, and was recently approved for adults as well. It is notable for being a non-stimulant treatment option, unlike many of the other common ADHD medications

Indications:

  • Initially approved by the FDA in 2021 for treating ADHD in children aged 6-17 years.
  • In April 2022, the FDA approved its use for adults with ADHD.
  • Qelbree vs Strattera offers a non-stimulant option, which makes it appealing for patients who want to avoid the risks associated with stimulant medications, such as addiction or misuse.

Advantages:

  • Lower risk of abuse: Because it’s non-stimulant, it doesn’t carry the same potential for abuse and dependence that stimulant medications do.
  • Less insomnia and anxiety: Compared to stimulants, Qelbree vs Strattera might cause fewer sleep disturbances and anxiety in some patients.

Additional information

Bottles of Capsules

30 Capsules, 60 Capsules, 90 Capsules, 120 Capsules

Reviews

There are no reviews yet.

Be the first to review “Qelbree”

Your email address will not be published. Required fields are marked *

Related Products

Ritalin LA

$180.00$980.00

Daytrana

$80.00$480.00

Ritalin

$250.00$1,450.00